HedgePath Pharmaceuticals Announces Notice of Allowance with Additional Claims Governing the Use of SUBA®-Itraconazole for the Treatment of Lung Cancer - Yahoo Finance

HedgePath Pharmaceuticals Announces Notice of Allowance with Additional Claims Governing the Use of SUBA®-Itraconazole for the Treatment of Lung Cancer  Yahoo Finance

New method of use claims in lung cancer enhance HedgePath's intellectual property estate relating to SUBA-Itraconazole. TAMPA, Fla., May 29, 2019 ...